RANI - Rani Therapeutics GAAP EPS of -$0.36 misses by $0.05
2023-11-09 13:33:11 ET
More on Rani Therapeutics
- Rani Therapeutics: Excellent Technology But Major Risks Ahead
- Canaccord believes Rani restructuring will help speed development
- Rani to cut 25% of workforce as it reprioritizes drug programs
- Seeking Alpha’s Quant Rating on Rani Therapeutics
- Historical earnings data for Rani Therapeutics
For further details see:
Rani Therapeutics GAAP EPS of -$0.36 misses by $0.05